Project Grant R44TR005381
- The Defense Health Agency awarded a $2,463,953 Project Grant to Biosensics LLC for the development of a "Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum." The award, made under the Military Medical Research and Development program (CFDA 12.420), will fund the creation of innovative wearable sensor technologies and cloud-based software solutions to enable remote monitoring and management of frontotemporal dementia and related...
- This Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program provides $302,668 to Hominin.ai Inc. to develop a software system for real-time monitoring of user health through movement analysis using commercially available wireless headphones. The goal is to translate ordinary human walking patterns into movement-based biomarkers that can identify early indicators of musculoskeletal or neurological diseases, predict health...
- This $490,501 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), supports Janusq LLC, a startup biotech company spun out of Case Western Reserve University, in developing a peptide-based therapy called HV-3 for the treatment of Huntington's disease (HD). The key objectives of this 16-month project are to: (1) perform preliminary safety and toxicity...
- This Project Grant award, valued at $503,930.00 and awarded by the National Science Foundation (NSF) under the Computer and Information Science and Engineering (CISE) Federal Grant Program (CFDA 47.070), supports the development of a wearable sensor network with distributed computing capabilities for advanced health monitoring and biomechanics analysis. The research aims to address key challenges associated with wearable technologies, such as limited computational power, battery capacity, data...
- This Project Grant award, totaling $826,902.00, was provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) to the Hugo W. Moser Research Institute at Kennedy Krieger, Inc. in Maryland. The goal of this 5-year project, which began on May 1, 2025, is to leverage wearable technology to investigate the dynamic relationships between physical activity, sleep, and circadian rhythms, and how they relate to the heterogeneity in clinical...
- The National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853), awarded a $459,097 Project Grant to Pison Technology, Inc., a minority-owned small business in Boston, Massachusetts. The grant, awarded on June 12, 2025, will fund the development of a digital biomarker for amyotrophic lateral sclerosis (ALS) using Pison's wrist-worn neural biosensor device. The goal is to leverage the...
- This federal Project Grant award of $1,102,500.00 from the Department of Health and Human Services National Institutes of Health (CFDA 93.310 - Trans-NIH Research Support) aims to develop a low-risk, high-performance device to restore complex movement and locomotion for individuals with paralysis. The key products and services to be delivered under this grant include: Training new "copilot" AI architectures that can use computer vision and non-invasive signals to infer a user's...
- The U.S. National Institute on Aging (NIA) awarded a $5,174,076 Cooperative Agreement grant under the Aging Research program (CFDA 93.866) to Biosensics LLC, a small business in Newton, Massachusetts. The purpose of the grant is to develop and qualify digital biomarkers to monitor motor function in individuals with Progressive Supranuclear Palsy (PSP) and Dementia with Lewy Bodies (DLB) using wearable sensor technologies. Specifically, the project will utilize Biosensics' PAMSYS and PAMSYS ULM...
- The National Science Foundation awarded a two-year, $199,967 Project Grant to The Trustees of the Stevens Institute of Technology under the Engineering (CFDA 47.041) federal grant program. The grant will support the development of a validation framework and open-source hardware/software sync platform for wearable motion analysis systems. Specifically, the grantee will establish novel data-driven methods and probabilistic/learning-based models to enable accurate time alignment between...
- Lifespan Digital Health LLC was awarded a $255,409 Project Grant from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop bio-behavioral technology and provide mental health services. Specifically, the company will use predictive algorithms, wearable technology, and peripheral autonomic biofeedback to provide timely data and enable mental health professionals to treat students. This innovative approach aims to address the...
This Project Grant award of $1,064,194.00 from the National Center for Advancing Translational Sciences (NCATS), CFDA #93.350, supports the development of a wearable sensor platform called HDWear for remote monitoring of motor impairment in Huntington's disease (HD) and prodromal HD. The award enabled a 12-month study that enrolled 41 participants (21 with clinically diagnosed HD, 8 classified as prodromal HD, and 12 healthy controls) to validate the utility of HDWear for monitoring physical activity and chorea in HD patients. The study found that while HD participants exhibited no significant change in motor scores, their physical activity levels decreased significantly over the 12-month period, while prodromal HD participants showed no change, highlighting the need for more sensitive metrics to capture early-stage disease progression. This grant supports the awardee, Biosensics LLC, a small business in Newton, Massachusetts specializing in digital health technologies, in advancing this remote monitoring platform for HD.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.1m | 9/4/25 |